Radioembolization gains continuous traction as a primarily palliative radiation treatment for
hepatic tumours. A form of nuclear medicine therapy, Yttrium-90 containing microspheres …

Primary liver tumours (ie hepatocellular carcinoma (HCC) or intrahepatic
cholangiocarcinoma (ICC)) are among the most frequent cancers worldwide. However, only …

The aim of this standard operational procedure is to standardize the methodology employed
for the evaluation of pre-and post-treatment absorbed dose calculations in 90 Y microsphere …

Selective internal radiation therapy has emerged as a well-accepted therapeutic for primary
and metastatic hepatic malignancies. This therapeutic modality requires the combined …

Liver metastases are a major cause of death from colorectal cancer. Intraarterial therapy
options for colorectal liver metastases include chemoinfusion via a hepatic arterial pump or …

Purpose To compare outcomes of yttrium-90 radioembolization performed with resin-based
(90 Y-resin) and glass-based (90 Y-glass) microspheres in the treatment of hepatocellular …

Transarterial radioembolization (TARE) with Yttrium-90 (90 Y) microspheres is a liver-
directed therapy for primary and metastatic disease. This manuscript provides a review of …

Purpose Patients with hepatocellular carcinoma and portal vein tumor thrombus have a poor
prognosis and limited therapeutic options. We sought to compare survival, tolerability, and …

Minimally invasive locoregional therapies have a growing role in the multidisciplinary
treatment of primary and metastatic breast cancer. Factors contributing to the expanding role …

Trans-arterial radioembolization (TARE) therapy confronts significant technical challenges in
the preparation of metal nuclide-labeled microsphere carriers, the development of stable …